Azacytidine for the Treatment of Myelodysplastic Syndromes/Acute Myeloid Leukemia (MDS/AML) With High Risk (Chromosome 7 and or Complex) Cytogenetic Abnormalities

Clinical trial NCT00915785 · COMPLETED

Trial details

NCT number: NCT00915785
Sponsor: King's College London
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndromes Leukemia, Myeloid, Acute

Start date: 2005-11-01
Primary completion: 2013-04-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.